June 21, 2015 | Teva Pharmaceutical Industries and Microchips Biotech announced a partnership to explore integrating Microchip’s implantable drug delivery device into Teva’s products. The goal of such a partnership would be to improve the outcomes for patients that engage in chronic therapy. Microchip’s innovative technology can administer drugs over a period of months to years, releasing the drugs at pre-determined times.
Related posts
Israel Invests Millions To Help AI Comprehend Hebrew, Arabic
September 21, 2023
Cybersecurity Startup Cato Raises $238M With $3B Valuation
September 21, 2023
Israel, UK Ink Deal For Greater Innovation Collaboration
September 21, 2023
ALS Drug Receives Patent In Israel, Europe, Japan
September 20, 2023
Facebook comments